112 related articles for article (PubMed ID: 23796562)
21. Integrated analysis of the differential cellular and EBV miRNA expression profiles in microdissected nasopharyngeal carcinoma and non-cancerous nasopharyngeal tissues.
Wan XX; Yi H; Qu JQ; He QY; Xiao ZQ
Oncol Rep; 2015 Nov; 34(5):2585-601. PubMed ID: 26330189
[TBL] [Abstract][Full Text] [Related]
22. Polymorphisms in the endothelin-1 and endothelin a receptor genes and survival in patients with locoregionally advanced nasopharyngeal carcinoma.
Wen YF; Qi B; Liu H; Mo HY; Chen QY; Li J; Huang PY; Ye YF; Zhang Y; Deng MQ; Guo X; Hong MH; Cao KJ; Mai HQ
Clin Cancer Res; 2011 Apr; 17(8):2451-8. PubMed ID: 21487064
[TBL] [Abstract][Full Text] [Related]
23. Hsa-miR-24-3p increases nasopharyngeal carcinoma radiosensitivity by targeting both the 3'UTR and 5'UTR of Jab1/CSN5.
Wang S; Pan Y; Zhang R; Xu T; Wu W; Zhang R; Wang C; Huang H; Calin CA; Yang H; Claret FX
Oncogene; 2016 Nov; 35(47):6096-6108. PubMed ID: 27157611
[TBL] [Abstract][Full Text] [Related]
24. Significance of microRNA-related variants in susceptibility to recurrence of oropharyngeal cancer patients after definitive radiotherapy.
Chen X; Sturgis EM; Wang C; Cao X; Li Y; Wei Q; Li G
Oncotarget; 2016 Jun; 7(23):35015-25. PubMed ID: 27145460
[TBL] [Abstract][Full Text] [Related]
25. Identification of a microRNA signature associated with risk of distant metastasis in nasopharyngeal carcinoma.
Bruce JP; Hui AB; Shi W; Perez-Ordonez B; Weinreb I; Xu W; Haibe-Kains B; Waggott DM; Boutros PC; O'Sullivan B; Waldron J; Huang SH; Chen EX; Gilbert R; Liu FF
Oncotarget; 2015 Feb; 6(6):4537-50. PubMed ID: 25738365
[TBL] [Abstract][Full Text] [Related]
26. The effects of functional polymorphisms in the TGFβ1 gene on nasopharyngeal carcinoma susceptibility.
Hu S; Zhou G; Zhang L; Jiang H; Xiao M
Otolaryngol Head Neck Surg; 2012 Apr; 146(4):579-84. PubMed ID: 22282866
[TBL] [Abstract][Full Text] [Related]
27. miR‑495 enhances the efficacy of radiotherapy by targeting GRP78 to regulate EMT in nasopharyngeal carcinoma cells.
Feng X; Lv W; Wang S; He Q
Oncol Rep; 2018 Sep; 40(3):1223-1232. PubMed ID: 30015969
[TBL] [Abstract][Full Text] [Related]
28. miR-16 targets fibroblast growth factor 2 to inhibit NPC cell proliferation and invasion via PI3K/AKT and MAPK signaling pathways.
He Q; Ren X; Chen J; Li Y; Tang X; Wen X; Yang X; Zhang J; Wang Y; Ma J; Liu N
Oncotarget; 2016 Jan; 7(3):3047-58. PubMed ID: 26655091
[TBL] [Abstract][Full Text] [Related]
29. Post-treatment serum lactic dehydrogenase as a predictive indicator for distant metastasis and survival of patients with nasopharyngeal carcinoma.
Wang J; Li L; Dong BQ; Xu YJ; Zheng YD; Sun ZW; Yang Y; Chen YY; Chen XZ; Chen M
Oncotarget; 2016 May; 7(19):27458-67. PubMed ID: 27050275
[TBL] [Abstract][Full Text] [Related]
30. Polymorphisms in host immune response associated genes and risk of nasopharyngeal carcinoma development in Portugal.
Sousa H; Mesquita L; Ribeiro J; Catarino R; Breda E; Medeiros R
Immunobiology; 2016 Feb; 221(2):145-52. PubMed ID: 26391153
[TBL] [Abstract][Full Text] [Related]
31. Polymorphisms of NFκB1 and IκBα and Their Synergistic Effect on Nasopharyngeal Carcinoma Susceptibility.
Liu Y; Qiu F; Yang L; Yang R; Yang X; Huang D; Fang W; Zhang L; Jiang Q; Zhang L; Zhou Y; Lu J
Biomed Res Int; 2015; 2015():362542. PubMed ID: 26161396
[TBL] [Abstract][Full Text] [Related]
32. XRCC3 polymorphisms are associated with the risk of developing radiation-induced late xerostomia in nasopharyngeal carcinoma patients treated with intensity modulation radiated therapy.
Zou Y; Song T; Yu W; Zhao R; Wang Y; Xie R; Chen T; Wu B; Wu S
Jpn J Clin Oncol; 2014 Mar; 44(3):241-8. PubMed ID: 24453273
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-152 Targets Phosphatase and Tensin Homolog to Inhibit Apoptosis and Promote Cell Migration of Nasopharyngeal Carcinoma Cells.
Huang S; Li X; Zhu H
Med Sci Monit; 2016 Nov; 22():4330-4337. PubMed ID: 27840403
[TBL] [Abstract][Full Text] [Related]
34. Clinical utility of plasma Epstein-Barr virus DNA and ERCC1 single nucleotide polymorphism in nasopharyngeal carcinoma.
Hui EP; Ma BB; Chan KC; Chan CM; Wong CS; To KF; Chan AW; Tung SY; Ng WT; Cheng AC; Lee VH; Chan SL; Loong HH; Kam MK; Leung SF; Ho R; Mo F; Ngan RK; Chan AT
Cancer; 2015 Aug; 121(16):2720-9. PubMed ID: 25946469
[TBL] [Abstract][Full Text] [Related]
35. Minicircle-oriP-miR-31 as a Novel EBNA1-Specific miRNA Therapy Approach for Nasopharyngeal Carcinoma.
Wu J; Tan X; Lin J; Yuan L; Chen J; Qiu L; Huang W
Hum Gene Ther; 2017 May; 28(5):415-427. PubMed ID: 28042945
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-378 functions as an onco-miR in nasopharyngeal carcinoma by repressing TOB2 expression.
Yu BL; Peng XH; Zhao FP; Liu X; Lu J; Wang L; Li G; Chen HH; Li XP
Int J Oncol; 2014 Apr; 44(4):1215-22. PubMed ID: 24481647
[TBL] [Abstract][Full Text] [Related]
37. miR-9 targets CXCR4 and functions as a potential tumor suppressor in nasopharyngeal carcinoma.
Lu J; Luo H; Liu X; Peng Y; Zhang B; Wang L; Xu X; Peng X; Li G; Tian W; He ML; Kung H; Li XP
Carcinogenesis; 2014 Mar; 35(3):554-63. PubMed ID: 24170200
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-124-3p inhibits the growth and metastasis of nasopharyngeal carcinoma cells by targeting STAT3.
Xu S; Zhao N; Hui L; Song M; Miao ZW; Jiang XJ
Oncol Rep; 2016 Mar; 35(3):1385-94. PubMed ID: 26707908
[TBL] [Abstract][Full Text] [Related]
39. Multigene pathway-based analyses identify nasopharyngeal carcinoma risk associations for cumulative adverse effects of TERT-CLPTM1L and DNA double-strand breaks repair.
Yee Ko JM; Dai W; Wun Wong EH; Kwong D; Tong Ng W; Lee A; Kai Cheong Ngan R; Chung Yau C; Tung S; Li Lung M
Int J Cancer; 2014 Oct; 135(7):1634-45. PubMed ID: 24615621
[TBL] [Abstract][Full Text] [Related]
40. Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma.
Lu JJ; Kong L; Shakespeare TP; Loh KS; Zhang Q; Tan KS; Lee KM
Oral Oncol; 2008 Jul; 44(7):703-9. PubMed ID: 18061528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
